In contrast to the relatively high attention paid to the structural heterogeneity of striatal dopamine (DA) innervation, little attention has been focused on the possible striatal heterogeneity for release and uptake of DA. By using amperometric methods, we found striatal regions showing a DA decrease during the medial forebrain bundle stimulation (drain areas) near to other zones that showed an increase in DA concentration (fountain areas). Both areas were intermixed to form a tridimensional matrix to regulate DA concentration throughout the striatum (fountaindrain matrix). The response to electrical stimuli of different amplitudes and durations and to different drugs (␣-methyl-Ltyrosine, cocaine, ␥-butyrolactone, and haloperidol) suggests that regional differences for both DA release/DA uptake and DA cell firing autoregulation are behind the striatal fountain-drain matrix. The high diversity of DA activity observed in the striatum is a new framework for analyzing experimental and clinical phenomena.
The striatum is the largest structure of the basal ganglia, where its medium-sized spiny neurons process basal ganglia inputs coming from all cortical areas and return the processed information to the cortex via the "direct" (striatumsubstantia nigra/internal pallidum-thalamus-cortex) and "indirect" (striatum-external pallidum-subthalamus-substantia nigra/internal pallidum-thalamus-cortex) pathways. Therefore, it is involved in forming a closed loop that connects the subcortical projections from each cortical area with the thalamic projections to the same cortical area (Alexander et al., 1986; Albin et al., 1989; DeLong, 1990; Smith et al., 1998; Obeso et al., 2000b) . The striatum is massively innervated by mesostriatal dopamine (DA) cells, which, by modulating the cortical action on medium-sized spiny neurons (Dahlstroem and Fuxe, 1964; Ungerstedt, 1971; Fallon and Moore, 1978; Gerfen et al., 1987b; Joel and Weiner, 2000) , influence motor and nonmotor functions of the cortex (Gerfen, 2000) . At a subcellular level, DA actions are induced at both the synaptic cleft (where DA behaves as a short-lasting neurotransmitter) and the extracellular nonsynaptic space (where it behaves as a long-lasting volume transmitter) (Gonon, 1988; Kawagoe et al., 1992; Sesack et al., 1994; Descarries et al., 1996; Schultz, 1998) . The role of each DA pool and the interaction between them is still being researched.
Based on the distribution of different neurochemical markers, the striatum has been segregated into two intricately related compartments, the striosoma (i.e., patch), which has a high density for substance P, dynorphin, and neurotensin markers, and the matrix which has a high density for cholinergic enzymes and calbindin (Goldman-Rakic, 1982; Groves et al., 1988; Graybiel, 1990) . There is also a nonhomogeneous DA distribution across the striatum, with local heterogeneity for DA innervation (Voorn et al., 1986; Gerfen et al., 1987a,b; Graybiel et al., 1987; Langer et al., 1991; Gerfen, 1992a,b; Joel and Weiner, 2000) , DA concentration (Voorn et al., 1986) , tyrosine hydroxylase level (Gerfen et al., 1987b (Gerfen et al., , 1992a , DA receptor (Gerfen et al., 1990) , and DA transporter (DAT) (Graybiel et al., 1993; Gonzalez-Hernandez et al., 2004) density. A part of this heterogeneity has been linked to the striosoma/matrix dichotomy (Gerfen et al., 1987b; Graybiel and Moratalla, 1989; Halpain et al., 1990; Hanley and Bolam, 1997) . There are electrochemical works suggesting regional diversity for striatal DA transmission (May and Wightman, 1989; Peters and Michael, 2000) , but these differences have not been systematically evaluated. In the present work, the regional diversity for DA activity was studied in the striatum by quantifying extrasynaptic DA with a selective and sensitive amperometric method that made it possible to analyze the local heterogeneity of DA response to medial forebrain bundle (MFB) stimulation and its modulation by DA receptor and DAT activity.
Materials and Methods
Experiments were carried out on male Sprague-Dawley rats weighing 300 to 350 g. Animals were housed at 22°C, two per cage, under normal laboratory conditions on a standard 12-h light/dark schedule (with 3:00 AM to 3:00 PM, lights on) and free access to food and water. Experiments were carried out in accordance with the European Communities Council Directive of November 24, 1986 (86/609/EEC) regarding the care and use of animals for experimental procedures, and adequate measures were taken to minimize pain and discomfort.
Electrodes and Electrochemical Methods. DA concentration was quantified here with two high-temporal resolution (Ͻ1 s) electrochemical methods, amperometry (Dugast et al., 1994; Gonon, 1997; Benoit-Marand et al., 2001; Puopolo et al., 2001 ) and fast cyclic voltammetry (FCV) Wightman et al., 1988; Wightman and Zimmerman, 1990; Wu et al., 2001) . The recording electrode was a carbon fiber microelectrode (8-m diameter and 100 m long), whose tip was pulled to Ϸ1 m (Fu and Lorden, 1996) to minimize tissue damage (Fig. 1A) . As an additional precaution, the electrode was very slowly introduced in the striatal tissue (20 m/min) with a micromanipulator (MO-8; Narishige, Tokyo, Japan) modified in our laboratory to include a stepper motor and a digital controller for vertical displacement (1-m resolution; Sylvac, Crissier, Switzerland). The response to MFB stimulation was tested every 50 m (half the length of the carbon fiber electrodes) and 5 min after the last movement. Electrodes were pretreated for 20 s with a 70-Hz triangular wave (0 -2.3 V versus Ag/AgCl) to optimize their in vivo electrochemical behavior. This treatment causes a very small decrease in the time resolution of electrode (compare 2.5-V-treated electrodes in Fig. 1B with that obtained in untreated electrodes and in 2.9-V-treated electrodes). The sensitivity of the electrodes was approximately 50 times higher (Ͼ1 nM) than that obtained with untreated electrodes. The reference electrode (silver wire in vitro coated with a layer of silver chloride by applying ϩ5 V for 3 min) was placed inside a pulled glass capillary tube (filled with a 3 M potassium chloride solution saturated with AgCl; Fluka, Madrid, Spain) with a 300-m-diameter tip. . C1, increase of sensitivity after electrode treatment; maximal response in 10 electrodes [amperometric response to DA was evaluated in ascorbic acid (AA) or glutathione (glt) solutions] (data are shown as mean Ϯ S.E.). C2, increase of sensitivity after electrode treatment; an example of the amperometric current at different oxidation potentials (amperometric response to DA was evaluated in AA or glt solutions). Dashed line, response of phosphate-buffered saline. C3, differential sensitivity for DA and pH in treated electrodes (mean Ϯ S.E. of 20 measures). D, in vitro selectivity of the electrode shown as amperometric current at different oxidation potential (BKG, background; 5HT, . An example of 12 striatal response waves to MFB stimulation recorded at 200-and 0-mV oxidation potential are shown in E and F, respectively. Electrical artifacts induced by the stimulation pulses on the amperometric signal were withdrawn using two different methods: 1, subtraction of the mean response obtained at 0 V (electrical artifacts) from that obtained at 250 mV (DA oxidation ϩ electrical artifacts) (G); and 2, a moving average of the response wave (H).
Electrode Calibration and Testing. Selectivity and sensitivity of electrochemical methods and electrodes were tested before their implantation. The active part of the carbon fiber electrode was placed 5 mm into a Teflon capillary tubing (125-m i.d. and 5 cm in length), which was connected to the exit of a liquid switch (CMA110; CMA Microdialysis, Stockholm, Sweden), which was in turn connected to a dual syringe perfusion pump (CMA102; CMA Microdialysis). The perfusion fluid was a phosphate-buffered saline solution (148 mM NaCl, 2.7 mM KCl, 1.2 mM CaCl 2 , and 0.8 mM MgCl 2 ), and the flow rate was 40 l/min. Oxidizable compounds were dissolved in this solution and loaded in one of the two perfusion syringes (the other was loaded with the solution used to dissolve the test compound). The internal volume of the whole system was 40 l.
In Vivo Preparation. Following previously reported procedures (Rodriguez and Gonzalez-Hernandez, 1999) , in vivo studies were performed under chloral hydrate anesthesia (400 mg/kg i.p.) in a sound-proofed dark room (5:00 AM to 10:00 PM after turning the lights on) with the body temperature maintained between 36.5 and 37.0°C. According to previous studies (Chergui et al., 1994; Gonon, 1997) , DA released during the electrical stimulation of the MFB was monitored with a carbon fiber microelectrode introduced in the striatum. The electrode was connected to an amperometry detector (BECA Instruments, Tenerife, Spain) that controlled the electrode potential (versus a reference electrode whose open tip was immersed in a saline solution in contact with the meninges through a previously made hole in the skull) by means of a potentiostat. The location of the striatal recording electrode was 0.0 to 1.2 mm anterior to bregma, 2.6 to 3.4 mm lateral to the midline, and 3.8 to 5.0 mm below the cortical surface. Activation of DA inputs to the striatum was performed by the electrical stimulation of the MFB (electrode placed in a position 4 mm anterior to lambda, 1.4 mm lateral to the midline, and 8.0 mm below the cortical surface). Electrical stimuli were provided by an S-8800 Grass model and a bipolar electrode made with two tungsten rods (100-m diameter; A-M Systems Inc., Everett, WA) etched with a oxyacetylene torch flame (Braga et al., 1977) , insulated with glass (fused silica capillary; Composite Metal Service, Hallow, UK) and placed with the tips 500 m apart. The exposed surface of the tip was approximately 0.5 mm. Stimuli were given in 0.2 to 0.7 mA and 1-ms square biphasic pulses. The striatal DA concentration change induced by the MFB stimulation was estimated on the basis of the calibration of the carbon fiber electrodes before their implantation.
In the last experiments, the effect of DA depletion on striatal response to MFB stimulation was tested. Thus, ␣-methyl-L-tyrosine (AMPT) was i.p. injected (250 mg/kg) during the periodic stimulation of MFB (20 -30 Hz, 0.3 mA/1.0 -1.5-s stimulus duration, each 20 -60 s). Sixty minutes after AMPT administration, extracellular DA was replenished by injecting exogenous dopamine (5 mM) throughout a fused silica capillary tube (75-m inner diameter) located 400 m from the recording electrode tip. DA was dissolved in a ringer solution (148 mM NaCl, 2.7 mM KCl, 1.2 mM CaCl 2 , and 0.8 mM MgCl 2 ) supplemented with L-glutathione reduced (1 mM) to avoid DA oxidation and whose osmolarity (auto-osmometer Osmostat OM-6020; CagaK Co. LTD, Kyoto, Japan) was between 280 and 285 mOsm. Two DA fluxes were used (CMA-102 Microdialysis pump; CMA), one which induced a fast and transitory increase of extracellular DA (3 l/min for 3 s; Fig. 8D ) and the other, which induced a slow and progressive increase of DA (continuous perfusion of 0.2 l/min; Fig. 8E ).
Amperometry Method. Amperometry uses a continuous oxidation potential (0.4 V for DA) that, although less selective than FCV, provides a very high sensitivity (nanoamperes) and time resolution (microseconds). The amperometry method used here was similar to that previously used by others (Chergui et al., 1994; Gonon, 1997; Staal et al., 2004) , with some modifications aimed at optimizing its selectivity for DA and its time and spatial resolution. Amperometric current through the electrode was continuously measured with a time constant of 1 ms, and the detector output was digitized and recorded at 1 kHz (PowerLab system connected to a PC computer; ADInstruments, Castle Hill, Australia). It has been shown that the rapid increase in the current evoked in the striatum by MFB electrical stimulation is caused entirely by the evoked DA overflow (Chergui et al., 1994; Dugast et al., 1994; Gonon, 1997) . As an additional precaution and to rule out the possible interference of serotonin, we used a potential of 200 mV instead of the 0.4-V oxidation potential that is generally used for DA (Fig. 1D) . In some experiments, the amperometric response was tested at different oxidation potentials. Thus, the oxidation potential was slowly modified between 800 and Ϫ800 mV, and the response to MFB stimulation was tested every 50 mV. A three-dimensional map of data (response amplitude ϫ poststimulus time ϫ oxidation potential) was computed and visualized with a color plot similar to that previously used for FCV data (Peters and Michael, 2000) .
The electrical artifacts induced by the stimulation pulses on the amperometric signal were initially withdrawn using two methods, one previously used in other laboratories (Chergui et al., 1994; Dugast et al., 1994; Gonon, 1997) and the other reported here. With the previously reported method, a number of stimuli (12 in Fig. 1E ) are averaged, and the mean responses obtained at 0-V oxidation potential ( Fig. 1F ) are subtracted (electrical artifacts) from that obtained at 0.4 V (DA oxidation ϩ electrical artifacts). Thus, the artifact can be reduced without disturbing the amplitude of the amperometric response ( Fig. 1G) . We also tested a new method that noticeably decreased the stimuli artifact by decreasing the high-frequency components of the stimuli (square pulses were modified by shaving the pulse corners to obtain a stimulus wave form with the initial and final portions of the rising and falling phases, similar to those of a sigmoid wave form), and fast biphasic stimulating pulses were used; the artifact induced by each pulse was very symmetric and lasted 1 to 2 ms and was withdrawn by using a moving average that computed each signal value as the average of the data obtained a few milliseconds before and after it. This new procedure was used in most studies, because it is as efficient at rejecting artifacts as the previously reported method and it does not need the averaging of a number of amperometric responses that increase the time resolution of the study. As shown in Fig. 1H , all amperometric responses to MFB stimulation (and not only the mean recording; Fig. 1G ) can be used to quantify the experimental response with this method.
Fast Cyclic Voltammetry Method. FCV quantifies DA concentration by studying currents recorded when the oxidation potential is moved quickly between two boundaries (generally between 1.0 and Ϫ1.0 V). Under these conditions, most DA is oxidized in a range between 0.5 to 0.7 V. The FCV method used here was similar to that previously used by others Wightman and Zimmerman, 1990; Wu et al., 2002) . The electrode was held at 0 V, scanned to Ϫ1 V, ramped to 1.0 V, back to Ϫ1 V, and returned to 0 V. The duration of this cycle was 15 ms, and the cycle was repeated every 100 ms. Current through the electrode was continuously digitized at 20 kHz (PowerLab system connected to a PC computer; ADInstruments).
Drug and Chemicals. Haloperidol, ␥-butyrolactone (GBL), AMPT, L-glutathione reduced, and acetazolamide were obtained from Sigma Chemical Corp. (St. Louis, MO). Cocaine chlorohydrate was obtained from Avello (Barcelona, Spain).
Histology. To verify the location of the recording microelectrode, a lesion was made by passing direct current through the carbon fiber electrode (15 A of cathodal direct current for 50 s). At the end of each experiment, the rats were transcardially perfused with 200 ml of 0.9% saline solution followed by 400 ml of 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4. Brains were removed and stored in the same fixative at 4°C for 12 to 24 h, and then the midbrain was cut at 50 m with a vibratome in the coronal plane and stained with the formal thionine procedure.
Statistics. Mathematical analyses were performed using the oneway analysis of variance followed by the least significant difference test for post hoc comparisons. Analysis was performed using the
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Statistica program (Statsoft, Tulsa, OK). A level of p Ͻ 0.05 was considered as critical for assigning statistical significance.
Results
In most striatal regions, the amperometric current increased during the MFB stimulation, a response that will be referred to as type I response (type I R , Fig. 2A ). This response was similar to that previously reported by others, showing a response amplitude and a response duration that rose when the stimulation rate increased ( Fig. 2A) . This response has been considered previously as an indication of striatal DA release from stimulated DA inputs.
In some striatal regions, a current decrease was observed during MFB stimulation, a response that will be referred to as type II response (type II R , Fig. 2B ). The amplitude and duration of type II R also rose when the rate (Fig. 2B) and duration ( Fig. 2D ) of stimuli increased. Type II R often began after the stimulus switch-off when a low-rate stimulation was used (10 Hz in Fig. 2E ). In some recordings, type II R began during stimulation and lasted for 1 to 2 s after stimulus switch-off (40 Hz in Fig. 2E ). In this case, the stimulus Depending on the striatal region under study the oxidation current increased (type I R in A), decreased (type II R in B), or showed a mixed modification (type I/II R in C), responses that were directly related to the stimulus frequency (stimuli of 400 ms with frequencies between 5 and 30 Hz). Duration and amplitude of type II R also increased with the duration of the stimulus (from 200-2000 ms in D where 20-Hz stimuli were used). Depending on the stimuli frequency, the type II R began during stimulation or after stimulation switch-off (E; 1-s stimulus). Occasionally, the type II R began during stimulation but increased after the stimulation switch-off (F; 1-s stimuli). Type II R was observed at the oxidation potentials that correspond to DA and completely vanished when the oxidation potential was lower than 0 mV (G; 20 Hz, 1-s stimuli). The stimulus duration is shown in all pictures by a black column. rate needed to induce a within-stimulus response was often higher than that needed to induce only the poststimulus response (Fig. 2F ). Type II R was selective for the oxidation potential of DA (Fig. 2G ) and was not observed for potentials lower than 50 mV. The finding of type II R suggested that MFB stimulation decreases extracellular DA in certain striatal regions.
Finally, a mixture of type I R and type II R was also observed in some striatal regions (type I/II R ). In this case, type I R generally began before type II R and often delayed the beginning of type II R . In some striatal loci, type I R and type II R were equally vigorous. In this case, the response amplitude of both responses progressively increased with the stimulation rate (Fig. 2C) .
The response type was different and specific in each striatal position and changed when the electrode was moved to neighboring striatal regions, with type II R being more frequently observed in the dorsolateral edges of the striatum. Striatal loci with type I R will be referred to as fountain areas and those with type II R as drain areas. Figure 3 shows response examples recorded across a striatal tract. As can be observed, the response was very stable within each area (the response to two consecutive stimuli are shown in each region) but can be very different when the recording electrode was moved 200 m. The frequency for each response type clearly depends on the region of the striatum that is being recorded (e.g., it is more frequent in the dorsal regions of the striatum just under the corpus callosum than in the middle striatal zones). We did not perform a systematic screening of all striatal regions, and no information about the relative frequency for each response type is provided.
Cocaine Action. The possible involvement of dopamine transporter on the different response types was tested by administering cocaine, a transporter activity inhibitor. Cocaine increased the type I R (Fig. 4, A and C) , an effect observed for a wide stimulus range (200 -1200 ms in the Fig. 4B  example) . Cocaine induced a complex modification of type II R . In most cases, cocaine changed the type II R responses The Fountain-Drain Striatal Matrix 35 into a type I/II R . This change was observed in striatal regions showing a marked type II R preceded by a small type I R (Fig.  4D ) but also in regions showing a pure type II R (Fig. 4E) . In striatal areas showing a type I/II R , the cocaine effect (Fig. 4F ) was much more marked on type I R (600% increase) than on type II R (25% decrease).
GBL Action. The possible influence of DA nigrostriatal cell impulse flow on the different response types was tested by administering GBL, a drug that at high doses (injected here in a single dose of 750 mg/kg i.p.) inhibits the impulse flow of these neurons (Walters and Roth, 1972; Walters et al., 1973; Diana et al., 1991) . GBL induced a slight increase (30%) of type I R (Fig. 5, A and B) and a marked decrease (70%) of type II R (Fig. 5, C-E) . In regions showing a type I/II R , the initial type I R increased (to 300% of the basal response), and the posterior type II R decreased (to 25% of the basal response) after GBL administration (Fig. 5, F and G) .
Haloperidol Action. The possible involvement of DA cell receptors on the different response types was tested by administering haloperidol, a DA receptor antagonist that is partially selective for D2-like receptors. Haloperidol increased the type I R (Fig. 6A) . Type II R showed a marked attenuation (for example, see Fig. 6B ) after haloperidol administration to approximately 40% of its basal response (Fig.  6C) . In regions showing a type I/II R , the marked increase of the initial type I R together with the decrease of type II R made type II R undetectable (see 30 Hz in Fig. 6D ).
pH and Type II R . A recent FCV study has reported pH changes that could interfere with the DA signal after MFB stimulation (Venton et al., 2003) . Thus, we performed different studies to evaluate the possible involvement of pH on type II R with amperometry and FCV methods.
Initially, we tested in vitro the electrode sensitivity for DA and pH with amperometry methods. In this technique, electrodes showed a more marked sensitivity for DA concentration than for pH modification (Fig. 1C) . In addition, no DA-pH overlapping was observed at the oxidation potential typically used for DA quantification with amperometry methods. Thus, for positive oxidation potentials, the DA wave increased with the oxidation potential (Fig. 7, D and G) , whereas no response was observed for pH pulses (Fig. 7, E and H). When negative oxidation potentials were used, a small response to DA was observed for potentials lower than Ϫ300 mV (Fig. 7, D and G) , whereas pH pulses induced a more marked effect, especially at Ϫ500 mV (Fig. 7, E and H) . These data show that when an oxidation potential of ϩ200 mV is used (i.e., in vivo studies), the pH change does not affect the amperometric signal (Fig. 7F) , at least when pH oscillates within the boundaries previously observed in the striatum (Ͻ0.1) after the MFB stimulation (Venton et al., 2003) .
The DA-pH segregation was not as evident for FCV, even when using the same in vitro preparation and the same electrodes as those previously used with amperometry. With this technique, DA induced an oxidation wave around 600 mV and a reduction wave around Ϫ200 mV (Fig. 7, I and L). On the other hand, the pH change (7.4 3 7.6) increased at oxidation potentials around Ϫ400 mV and decreased it at ϩ600 mV (Fig. 7J) . Therefore, the positive peak induced by DA at ϩ600 mV could be reduced by a negative peak induced by a simultaneous increase of pH (Fig. 7K) . In agreement with a previous study, present data suggest that care should be taken not to misinterpret pH shifts accompanying terminal activity as DA changes when FCV is used (Venton et al., 2003) . In this respect, the amperometric evaluation of DA at ϩ200 mV did not have the same pH interference problem as FCV.
Finally, acetazolamide (a carbonic anhydrase inhibitor that selectively decreases the pH response to MFB stimulation without modifying the DA response) (Venton et al., 2003) was used for in vivo testing the possible influence of pH on type II R with amperometric methods. This amperometric study showed that after drug administration, no type II R modifications were observed (Fig. 7A ) either in the response amplitude (Fig. 7B ) or in the response latency (time taken by the oxidation current to reach its minimal point) (Fig. 7C) . Taken together, present data show that pH modifications cannot explain type II R .
Tyrosine Hydroxylase Inhibition and Dopamine Action. This experiment was aimed at obtaining direct evidence of DA involvement on type II R . Thus, the effect of ␣-methyl-p-tyrosine (an inhibitor of the rate-limiting enzyme tyrosine hydroxylase) (Michael et al., 1987; Watanabe et al., 2005) on type II R was evaluated before and 50 to 120 min after AMPT administration, and then (120 -200 min after AMPT) DA was directly perfused in the striatum with phasic (3 l/min ϫ 3 s) or tonic (0.2 l/min ϫ 1 min) perfusion rates. AMPT dramatically reduced type II R in three of the six rats studied, decreasing both the response amplitude (Fig. 8C , left) and the response duration (Fig. 8C, right) . In the other three rats, a complete disappearance of type II R was observed after AMPT (Fig. 8B ). In rats with complete type II R disappearance, DA perfusion increased the amperometric current, inducing a fast and transitory increase (phasic perfusion; Fig. 8D ) or a slow and progressive increase (tonic perfusion; Fig. 8E) . A recovery of the type II R that disappeared after The Fountain-Drain Striatal Matrix 37 AMPT was observed after both the phasic DA administration (Fig. 8D) and the tonic DA administration (Fig. 8E) . In the second case, the type II R recovery was progressive and followed the slow increase of the amperometric current induced by DA perfusion.
Discussion
The present study reports a marked diversity for DAergic activity in the striatum, where some regions showed an extracellular DA increase after MFB stimulation (type I R in fountain areas), whereas other regions showed a DA decrease (type II R in drain areas). In addition, a mixed type I R /type II R response was observed in the same striatal region (type I/II R in mixed areas). Both the disappearance of type II R after AMPT and its recovery by local DA perfusion in the striatum show that type II R is the consequence of a transitory decrease of extracellular DA. The cocaine, GBL, and haloperidol effects suggest that DA receptors and DAT modulate type II R . The finding of fountain-drain areas intermixed across the striatum is a new framework for analyzing experimental (e.g., the high DA diffusion observed in the striatum after the partial degeneration of DA cells) and clinical (e.g., dyskinesias and other motor complications often observed in Parkinson's disease after chronic DA drug administration or DA cell striatal implants) phenomena.
Type I R . Type I R showed the typical DA response to MFB stimulation reported in previous voltammetry Wu et al., 2001 ) and amperometry (Chergui et al., 1994; Dugast et al., 1994) studies. The extracellular DA concentration is generally the result of two opposing mechanisms: DA release and DA uptake. It has been shown that the increase of the electrochemical signal observed after MFB stimulation is induced by an excess of DA release that, after saturating DAT, diffuses until the recording electrode (DA overflow) (Wightman and Zimmerman, 1990; Gonon, 1997; Wu et al., 2001) . From this perspective, the rapid decrease of the electrochemical signal observed after the MFB stimulation switch-off (which corresponds to a fast DA concentration decrease) is induced by an efficient activity of DAT (although DA diffusion may play a minor role); the type I R increase induced by cocaine is secondary to a DA uptake inhibition (thus facilitating DA overflow) (Greco and Garris, 2003) ; and the type I R increase induced by haloperidol is secondary to a blockade of the receptor-mediated presynaptic self-inhibition (thus facilitating DA release and inhibiting DA uptake) (Benoit-Marand et al., 2001; Wu et al., 2002) . The mechanisms for the GBL actions here reported are less evident. Bearing in mind the above-mentioned model, the type I R increase observed after GBL administration could be induced by the persistent reduction of extracellular DA secondary to the GBL-induced inhibition of DA cell firing rate (Walters et al., 1973; Bannon et al., 1981 Bannon et al., , 1982 . This hypothesis explains the similar effect observed for GBL (which decreases the presynaptic DA receptor stimulation as a consequence of an extracellular DA concentration decrease) and haloperidol (which decreases the presynaptic DA receptor stimulation as a consequence of a direct blockade) administration.
Type II R . Some previous electrochemical studies have suggested a regional diversity for striatal DA transmission (May and Wightman, 1989; Peters and Michael, 2000) , but, as far as we know, this is the first article reporting striatal regions that respond to the MFB stimulation with a decrease of extracellular DA (type II R ). The finding of type II R increases in some experimental conditions (use of bipolar short-lasting electrical stimuli, highly sensitive pretreated electrodes and electrochemical methods, and short carbon fibers that reduce the probability of recording adjacent fountain and drain regions simultaneously) and decreases in others (use of longlasting high-frequency stimuli that increase the type I component of type I R /II R , recording in nonperipheral regions of the striatum where the finding of type II R is more common, and administration at the beginning of experiments of repetitive stimuli with short interstimulus). Although a mixture of all these factors can markedly reduce the probability of finding drain regions, we cannot explain why type II R has never been previously reported. We believe that this response has probably been observed in other laboratories, but it was never systematically studied because its biological explanation and significance are less evident than for type I R .
At the beginning, we found evidence suggesting that type II R was not produced by collateral nondopaminergic associated phenomena such as electrical artifact, modifications in other transmitters, or modifications in pH or oxygen. Type II R vanished after decreasing the oxidation potential (Fig.  2G) , which shows that it is not a nonspecific artifact induced by MFB stimulation. The amperometric conditions used also suggest that type II R is not the consequence of changes in other neurotransmitters such as serotonin [the oxidation potential used does not oxidate serotonin (Fig. 1D) , and the position of MFB electrodes made the stimulation of serotonergic ascending fibers very improbable] and GABA (GABA is not directly detectable with present methods) released from nondopaminergic mesostriatal neurons. Another two possible confusing variables are oxygen and pH, which can be Fig. 7 . Type II R and pH: in vivo and in vitro studies. An example of acetazolamide in vivo action on type II R is shown in A. Acetazolamine (25 mg/kg i.p. in saline solution) did not induce any modification in the response amplitude (B) and duration of the oxidation current decrease during the first portion of type II R (C). Data in B and C were recorded 25 to 50 min after drug administration (n ϭ 30 stimuli in three rats) and are shown as a percentage of the mean predrug value (ϮS.E.). The sensitivity of amperometry (D-H) and FCV (I-L) methods to DA and pH changes was also tested in vitro. The amperometric response to DA and pH modifications was tested at different oxidation potentials with a voltage interval of 50 mV. Two precautions were taken to facilitate the stabilization of the baseline before a new oxidation potential was studied: 1, oxidation potentials were moved from positive to negative values (which facilitates the rapid stabilization of the baseline); and 2, at least ten min elapsed between the voltage modification and the next amperometric recording. An example of these recordings, computed as a three-dimensional map (response amplitude ϫ poststimulus time ϫ oxidation potential), is visualized in a color plot in D (DA) and E (pH). DA-pH overlapping was not observed at the oxidation potential (200 mV) typically used for in vivo studies (an example is shown in F; blue line, DA; red line, pH). The maximum amplitude of FCV response to DA and pH change is shown in G and H, respectively (mean of type II R maximum amplitude Ϯ S.E.). An example of the FCV voltamogram (Faradic current for oxidation and reduction plotted against the input voltage to the potentiostat to form a cyclic representation) recorded in basal (red line) and in a 2 M DA solution (blue line) is shown in L. Similar to the amperometric data computation, the FCV was also visualized as a three-dimensional map (response amplitude ϫ poststimulus time ϫ oxidation potential). An FCV example (recorded with the same electrode used in the amperometry study shown in D and E) is shown in I (DA) and J (pH). DA pH overlapping was observed at the oxidation potential (600 mV) generally used in in vivo studies (an example in shown in K; blue line, DA; red line, pH).
The Fountain-Drain Striatal Matrix detected by carbon fiber electrodes and change in the striatum after MFB stimulation (Zimmerman and Wightman, 1991; Zimmerman et al., 1992; Cramer et al., 1997; Venton et al., 2003) . DA oxidation and oxygen reduction occur at different potentials (ϩ0.3 and Ϫ1.4 V, respectively) (Zimmerman et al., 1992; Venton et al., 2003) and show a different kinetic response (Venton et al., 2003) , ruling out the oxygen involvement on type II. Previous (Venton et al., 2003) and present data show a partial overlapping between pH and DA signals when studied with FCV. However, this was not the case for amperometry. Thus, in vitro studies showed DA and pH amperometric waves that did not overlap at the oxidation potential used in in vivo studies (ϩ200 mV). In addition, acetazolamide, a drug that decreases the pH response to MFB stimulation but not the DA response (Venton et al., 2003) , did not change type II R . The pH changes previously observed with FCV after MFB stimulation are slower (began 2 s after stimulation) and longer lasting (Ͼ30 s) than type II R studied here (which generally began during stimulation and persisted for only a few seconds). Thus, in vitro (no pH wave at ϩ200-mV oxidation potential) and in vivo (no type II R modification after acetazolamide administration and a different kinetic for type II R to that reported for pH response) studies do not support pH modifications as the basis for type II R .
On the other hand, we found evidence showing that, similarly to that previously reported for type I R , type II R is produced by a short-lasting modification of the DA concentration. Thus, type II R changed after administration of drugs that modify DA synapse (cocaine, haloperidol, and AMPT) and DA cell firing activity (GBL). Data obtained after DA synthesis inhibition were particularly significant. Type II R markedly decreased or completely vanished after inhibiting tyrosine hydroxylase activity with AMPT, showing that this response needs endogenous catecholamines. Under these circumstances, type II R was quickly restored by the local perfusion of DA in the striatum, showing that this is the catecholamine involved in type II R . Contrary to the DA increase associated with type I R (Chergui et al., 1994; Dugast et al., 1994; Gonon, 1997) , type II R is caused by a transitory de- Type II R disappeared after AMPT administration (left) and was recovered after the local DA perfusion (right). D, example of amperometric response to DA tonic administration (perfusion of 0.2 l/min for 20 min). Type II R disappeared after AMPT administration showed a progressive recovery during the progressive arrival (as shown by the increase of the amperometric signal) of injected DA.
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crease in the extracellular DA concentration. Thus, the DA cell firing rate activation can increase (Wightman and Zimmerman, 1990; Gonon, 1997; Wu et al., 2001) or decrease extracellular DA, with the striatal region under study being the factor determining one response or the other.
Mechanisms to Explain Type II R . Two factors could be involved in the type I R /type II R dichotomy observed in different regions of the striatum: anatomical differences in the DA innervation versus DAT density proportion (Ciliax et al., 1995; Gonzalez-Hernandez et al., 2004) and functional differences of mechanisms involved in the DAT activation induced by DA cell spike firing (Meiergerd et al., 1993; Falkenburger et al., 2001; Khoshbouei et al., 2003; Mortensen and Amara, 2003) . It has been suggested that the electrochemical heterogeneity of the striatum could be related to the striosoma/ matrix architecture of this center (May and Wightman, 1989) . However, the functional organization of the striatum (Alexander and DeLong, 1985a,b; Graybiel, 1990) , and the heterogeneity for DA innervation (Voorn et al., 1986; Gerfen et al., 1987a,b; Graybiel et al., 1987; Langer et al., 1991; Gerfen, 1992a,b; Joel and Weiner, 2000) , DA concentration (Voorn et al., 1986) , DA receptor (Gerfen et al., 1990) , and DAT density (Graybiel et al., 1993; Gonzalez-Hernandez et al., 2004) do not always fit in with the striosoma/matrix architecture. We are presently trying to establish an electrochemical-morphological relationship between type II R and local density for DAT and D2 receptors. However, the electrochemical heterogeneity could be more qualitative (functional status) than quantitative (number of molecules). This might be the case for DAT, whose activity can quickly increase during cell hyperpolarization (Sonders et al., 1997; Falkenburger et al., 2001; Khoshbouei et al., 2003) or D2 autoreceptor stimulation (Meiergerd et al., 1993; Cass and Gerhardt, 1994; Mortensen and Amara, 2003) . The acute modification of type II R observed after the spike firing blockade with GBL or the D2 receptor inhibition with haloperidol supports this possibility. The explanation for type I R /II R could be a mixture of those proposed here for type I R and type II R . When DA release (more efficient in type I R regions) and DA uptake (more efficient in type I R regions) are balanced in one striatal region, a type I R /II R could be observed.
Possible Functional Meaning of Fountain-Drain Striatal Matrix. Bearing in mind the physical dimension of the electrode (8 ϫ 100 m) and the response modifications observed after small changes (200 -500 m) in the brain position of the electrode, present data suggest the existence of an intricate three-dimensional arrangement of fountaindrain regions within the striatum (fountain-drain striatal matrix). Besides other proposed regulatory mechanisms such as synaptic regulation of DA release (Benoit-Marand et al., 2001; Wu et al., 2002) or somatic regulation of the firing rate (Rodriguez et al., 2003a; Rodriguez et al., 2003b) , this fountain-drain matrix could provide another way to modulate the striatal action of DA. Considering the ability of DA to diffuse from the synaptic cleft and to cover long distances across the extracellular space (Kawagoe et al., 1992; Agnati et al., 1995; Descarries et al., 1996; Schultz, 1998; Hoistad et al., 2000) , the existence of highly effective striatal regions for sequestering DA excesses could prevent the deterioration of striatal activity induced by an excessive DA diffusion (Doucet et al., 1986; Schneider et al., 1994 ). An early FCV study of the electrochemical heterogeneity of the striatum (May and Wightman, 1989) found some characteristics in the voltammetric response to MFB stimulation (type I responses because no type II R was reported in this study), suggesting the existence of striatal regions particularly suitable for preventing an excessive DA diffusion ("mass transfer barrier"). Type II R of drain areas are a suitable substrate for this task. In this regard, disturbances in the fountain-drain matrix distribution may contribute to the deterioration of the therapeutic response generally observed in advanced Parkinson's disease. This is the case of dyskinesias, a motor complication often observed in Parkinson's disease after chronic DA drug administration (Cotzias et al., 1969; Fahn, 2000; Obeso et al., 2000a) and after DA cell implants (Lindvall and Hagell, 2000; Dunnett et al., 2001; Hagell and Brundin, 2001; Winkler et al., 2005) . Dyskinesias has been associated with a transitory increase of DA activity in specific striatal regions. Because DAT expression down-regulates in surviving DA neurons (Chinaglia et al., 1992; Miller et al., 1999; Pirker, 2003; Poewe and Scherfler, 2003; Gonzalez-Hernandez et al., 2004) , a functional mitigation of drain regions (perhaps together with other factors such as a loss of firing rate autoregulation) (Rodriguez et al., 2003a) probably facilitates the diffusion (Doucet et al., 1986; Schneider et al., 1994) and accumulation of DA, thus triggering motor complications.
In summary, we report here evidence showing a marked heterogeneity for the DA release and DA uptake in the striatum, where some regions show DA uptake activation during DA cell firing that is more intense than the corresponding DA release. Because these regions probably mitigate DA diffusion throughout the striatum, their disturbance could facilitate motor complications in basal ganglia disorders. Now we are analyzing the possible morphological basis for the fountain-drain matrix and identifying the synaptic mechanisms involved in type II R .
